Sunday, 26 June 2022

 

 

LATEST NEWS Aryans Law students participate in National Moot Court Competition at Indore Vigilance Bureau Recovers 12kg Gold, 3 Kg Silver, Four Iphones From Ias Officer Sanjay Popli’s House 47 years since the Emergency - 1975, BJP observes "Black Day" Lt Governor inaugurates Sukhnag Sozni Embroidery SFURTI Heritage Cluster of JK KVIB at Magam Budgam Lt Governor meets Industry Leaders from J&K Take every measure to restrict the spread of the virus : Dr. Arun Kumar Mehta DDC Reasi listens to public issues at Panchayat Seela DDC Udhampur reviews status of District Capex Budget works 7th anniversary of Smart Cities Mission: JSCL organises bicycle rally for media persons Jal Jevan Mission : DC Doda reviews project execution at district level Committee meeting DDC Chairperson conducts extensive tour of Panchayat Tirchi DC Srinagar stresses on strengthening of infrastructure in the Revenue Department Director RDD Kashmir holds interaction with Programme Officers National Rowing Championship: J&K clinch maiden medal in sub junior category, claim bronze DDC Rajouri reviews maintenance of Water Supply Schemes Cooperative Awareness Camp Sahakar Se Samriddhi organised in Poonch DDC Chairperson discusses maintenance of roads with Chief Engineer MES Farmers’ awareness cum training camp organized at village Subechak 3 day Cleanliness cum beautification drive concludes in PSPS Govt PG College for Women In 100 days, Mann government brings reforms in every major sector of Punjab : Malwinder Singh Kang Director Horticulture Kashmir conducts extensive tour of Baramulla

 

Elon Musk's Neuralink rival Synchron launches human trial of brain implant in US

Elon Musk , SpaceX CEO , Tesla CEO , San Francisco , SpaceX Project, Twitter, Neuralink

Web Admin

Web Admin

5 Dariya News

New York , 10 May 2022

Elon Musk's Neuralink rival Synchron has launched human trials on six severely paralysed patients in the US to enable them to control digital devices hands-free, using just thoughts.The US-based Synchron is an endovascular brain-computer (BCI) interface company that competes with Musk's Neuralink, which also aims to enable paralysed people to use computers and phones through their brain activities alone.In a statement, Synchron said that its device named Stentrode, which is the size of a paper clip, is implanted to the motor cortex of the brain through the jugular vein in a minimally-invasive procedure.Once implanted, it translates brain activity into a standardised digital language to allow patients to complete everyday tasks hands-free, on external devices including texting, emailing, online shopping and accessing telehealth services.

The company's new clinical trial will enrol six patients in New York and Pittsburgh with severe paralysis.The device has already been implanted and tested in four Australian patients, and the new clinical trial marks the first time it will be tested in the US.The trial on Australian patients demonstrated the technology to be safe, the company said.According to Tom Oxley, CEO and founder of Synchron, the new trials are "a major milestone for people living with paralysis".Rather than drilling through the skull, the Stentrode is fed through a patient's vein until it reaches the brain.The device, comprised of a net-like material with 16 sensors attached, expands to line the vessel wall. That device is connected to an electronic device in the chest that then relays the brain signals from the motor cortex, the part of the brain that generates signals for movement, into commands for a laptop computer.

Synchron is the only company to receive US Food and Drug Administration (FDA) approval to conduct clinical trials of a permanently implanted BCI. The company's novel BCI technology leverages the blood vessels as the natural highways to the brain.If successful, the Stentrode brain implant could be sold as a commercial product aimed at paralysis patients to regain their independence and quality of life.The company's new clinical trial, called Command, is being conducted under the first investigational device exemption (IDE) awarded by the FDA. An IDE allows a device to be used in a clinical study in order to collect data on its safety and effectiveness."The Command study progresses Synchron's technology development through the feasibility stage as we prepare for our pivotal trial," said Oxley.

 

Tags: Elon Musk , SpaceX CEO , Tesla CEO , San Francisco , SpaceX Project , Twitter , Neuralink

 

 

related news

 

 

 

Photo Gallery

 

 

Video Gallery

 

 

5 Dariya News RNI Code: PUNMUL/2011/49000
© 2011-2022 | 5 Dariya News | All Rights Reserved
Powered by: CDS PVT LTD